- Management of Chronic Kidney Disease-Mineral Bone Disorder with Sevelamer Hcl Phosphate Binder in Korean Patients with Dialysis
-
Shin SW, Sin HY
- KMID: 2358061
- Korean J Clin Pharm.
- 2016 Jun;26(2):97-106.
- doi: 10.0000/kjcp.2016.26.2.97
BACKGROUND: Sevelamer is associated with reduced complications of chronic kidney disease-mineral bone disorder (CKD-MBD) resulted from hyperphosphatemia, which may contribute mortality, in CKD patients with dialysis. So far clinical outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Calciphylaxis Treated with Phosphate Binder Sevelamer Hydrochloride in a Patient Who Was Operated on for Parathyroidectomy
-
Lee YS, Son HH, Choi JH, Lee SK
- KMID: 2247751
- Korean J Dermatol.
- 2009 Nov;47(11):1296-1299.
Calciphylaxis is a rare, but serious disorder that is usually observed in patients with renal disease and secondary hyperparathyroidism. It is characterized by the ischemic necrosis of the skin, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
-
Ghorbanihaghjo A, Argani H, Golmohamadi Z, Rashtchizadeh N, Abbasi MM, Bargahi N, Vatankhah , Sanajou D
- KMID: 2419842
- J Bone Metab.
- 2018 Aug;25(3):153-159.
- doi: 10.11005/jbm.2018.25.3.153
BACKGROUND: High serum phosphate and fibroblast growth factor-23 (FGF-23) levels are well-recognized independent risk factors of mortality and morbidity in patients with chronic kidney diseases (CKDs). Sevelamer, as a phosphate... -
- CITED
-
- Close
- SHARE
-
- Close
- Resolution of uremic tumoral calcinosis in a patient on peritoneal dialysis with long-term low-calcium dialysate treatment
-
Kim Y, Hwang E, Park S
- KMID: 2224266
- Kidney Res Clin Pract.
- 2014 Dec;33(4):226-228.
- doi: 10.1016/j.krcp.2014.09.002
Tumoral calcinosis is a rare complication in uremic patients. An in-depth review of published literature suggests that most patients with uremic tumoral calcinosis do not respond to medical treatment. Here,... -
- CITED
-
- Close
- SHARE
-
- Close
